share_log

TScan Therapeutics Q1 2024 GAAP EPS $(0.32) Misses $(0.26) Estimate, Sales $566.000 Miss $3.975M Estimate

Benzinga ·  May 13 19:05
TScan Therapeutics Q1 2024 GAAP EPS $(0.32) Misses $(0.26) Estimate, Sales $566.000 Miss $3.975M Estimate
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment